Contents

Current Drug Targets - CNS & Neurological Disorders, Volume 1 - Number 1

Preface

, 1(1): i

Ian A. McDonald


DOI: 10.2174/1568007023339481




Direct and Indirect Modulation of the N-Methyl D-Aspartate Receptor: Potential for the Development of Novel Antipsychotic Therapies

, 1(1): 1 - 16

M. J. Marino and P. Jeffrey Conn


DOI: 10.2174/1568007023339544




Multiple Sclerosis: Emerging Opportunities for Therapeutic Intervention

, 1(1): 17 - 30

C. F. Evans and L. P. Shriver


DOI: 10.2174/1568007023339526




Targeting the JNK Pathway for Therapeutic Benefit in CNS Disease

, 1(1): 31 - 49

Donna Bozyczko-Coyne, Michael S. Saporito and Robert L. Hudkins


DOI: 10.2174/1568007023339472




Oiling the Pipeline: The Path from Genomics to Drug Discovery for Brain Disease

, 1(1): 51 - 58

Christopher J. Winrow and Carrolee Barlow


DOI: 10.2174/1568007023339517




Small Molecule Trk Receptor Agonists and Other Neurotrophic Factor Mimetics

, 1(1): 59 - 80

Scott J. Pollack and Sarah J. Harper


DOI: 10.2174/1568007023339490




Recent Advances in the Modulation of Voltage-Gated Ion Channels for the Treatment of Epilepsy

, 1(1): 81 - 104

Nicholas D.P. Cosford, Peter T. Meinke, Kenneth A. Stauderman and Stephen D. Hess


DOI: 10.2174/1568007023339463




Constitutively Activated G Protein-Coupled Receptors: A Novel Approach to CNS Drug Discovery

, 1(1): 105 - 121

Frederique D.P. Menzaghi, Dominic P. Behan and Derek T. Chalmers


DOI: 10.2174/1568007023339508




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science